Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
805日前
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
1071日前
Bay Street Likely To Open On Positive Note
Canadian shares are likely to open higher Monday morning, with firm metal prices expected to trigger buying in the materials sector. The focus will be on the developments on the trade front and corporate earnings announcements.
RTTNews
|
2時54分前
FedEx Study Reveals $126 Bln Contribution In Direct & Indirect Impact To Global Economy In FY25
FedEx Corp. has contributed $126 billion in direct and indirect impact to the global economy in fiscal 2025, according to the logistics major's annual Global Economic Impact Report. The company delivered $1.6 billion in direct and indirect impact in the Middle East, Indian Subcontinent, and Africa or MEISA region.
RTTNews
|
3時15分前
UK Manufacturing PMI At 1-Year High
The UK manufacturing activity shrank in October but the pace of contraction was the slowest in a year, the final purchasing managers' survey from S&P Global revealed on Monday. The factory Purchasing Managers' Index rose to a 12-month high of 49.7 in October from 46.2 in September. The flash reading was 49.6.
RTTNews
|
3時27分前
Eurozone Manufacturing Sector Stagnates In October
Eurozone manufacturing sector stagnated in October, as initially estimated, following a fractional deterioration in September, the purchasing managers' survey compiled by S&P Global showed on Monday. The final Purchasing Managers' Index posted 50.0 in October, signalling no change in the operating conditions in the manufacturing sector. The score matched the initial estimate and remained above S
RTTNews
|
3時59分前
FTSE 100 Up Marginally In Cautious Trade
U.K.'s stock market's FTSE 100 is gaining some ground in positive territory on Monday, with stocks from the banking sector attracting attention ahead of the Bank of England's monetary policy announcement this week.
RTTNews
|
4時18分前
Fed's Hawkish Guidance Lifts Dollar
A drastic reduction in Fed rate cut hopes in the aftermath of the hawkish forward guidance by Chair Jerome Powell boosted the U.S. Dollar during the week ended October 31.
RTTNews
|
4時28分前
